CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in incidence of heart failures
3.4.1.2. Technological advancements
3.4.1.3. Rise in patient awareness about heart failure treatment options
3.4.1.4. Dearth of heart donors
3.4.2. Restraints
3.4.2.1. High cost of devices and procedures
3.4.2.2. Serious risks involved in the procedure
3.4.3. Opportunities
3.4.3.1. Lucrative opportunities in the emerging markets
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Left Ventricular Assist Devices (LVADs)
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Right Ventricular Assist Devices (RVADs)
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Biventricular Assist Devices (BIVADs)
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Bridge-To-Transplant (BTT)
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Destination Therapy
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Bridge-To-Recovery (BTR)
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Bridge To Candidacy Therapy
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN
6.1. Overview
6.1.1. Market size and forecast
6.2. Transcutaneous Ventricular Assist Devices
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Implantable Ventricular Assist Devices
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: VENTRICULAR ASSIST DEVICES MARKET, BY AGE
7.1. Overview
7.1.1. Market size and forecast
7.2. Adults
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Pediatrics
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
CHAPTER 8: VENTRICULAR ASSIST DEVICES MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Product
8.2.3. Market size and forecast, by Application
8.2.4. Market size and forecast, by Design
8.2.5. Market size and forecast, by Age
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Product
8.2.6.1.3. Market size and forecast, by Application
8.2.6.1.4. Market size and forecast, by Design
8.2.6.1.5. Market size and forecast, by Age
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Product
8.2.6.2.3. Market size and forecast, by Application
8.2.6.2.4. Market size and forecast, by Design
8.2.6.2.5. Market size and forecast, by Age
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Product
8.2.6.3.3. Market size and forecast, by Application
8.2.6.3.4. Market size and forecast, by Design
8.2.6.3.5. Market size and forecast, by Age
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Product
8.3.3. Market size and forecast, by Application
8.3.4. Market size and forecast, by Design
8.3.5. Market size and forecast, by Age
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Product
8.3.6.1.3. Market size and forecast, by Application
8.3.6.1.4. Market size and forecast, by Design
8.3.6.1.5. Market size and forecast, by Age
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Product
8.3.6.2.3. Market size and forecast, by Application
8.3.6.2.4. Market size and forecast, by Design
8.3.6.2.5. Market size and forecast, by Age
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Product
8.3.6.3.3. Market size and forecast, by Application
8.3.6.3.4. Market size and forecast, by Design
8.3.6.3.5. Market size and forecast, by Age
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Product
8.3.6.4.3. Market size and forecast, by Application
8.3.6.4.4. Market size and forecast, by Design
8.3.6.4.5. Market size and forecast, by Age
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Product
8.3.6.5.3. Market size and forecast, by Application
8.3.6.5.4. Market size and forecast, by Design
8.3.6.5.5. Market size and forecast, by Age
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Product
8.3.6.6.3. Market size and forecast, by Application
8.3.6.6.4. Market size and forecast, by Design
8.3.6.6.5. Market size and forecast, by Age
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Product
8.4.3. Market size and forecast, by Application
8.4.4. Market size and forecast, by Design
8.4.5. Market size and forecast, by Age
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Product
8.4.6.1.3. Market size and forecast, by Application
8.4.6.1.4. Market size and forecast, by Design
8.4.6.1.5. Market size and forecast, by Age
8.4.6.2. China
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Product
8.4.6.2.3. Market size and forecast, by Application
8.4.6.2.4. Market size and forecast, by Design
8.4.6.2.5. Market size and forecast, by Age
8.4.6.3. Australia
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Product
8.4.6.3.3. Market size and forecast, by Application
8.4.6.3.4. Market size and forecast, by Design
8.4.6.3.5. Market size and forecast, by Age
8.4.6.4. India
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Product
8.4.6.4.3. Market size and forecast, by Application
8.4.6.4.4. Market size and forecast, by Design
8.4.6.4.5. Market size and forecast, by Age
8.4.6.5. South Korea
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Product
8.4.6.5.3. Market size and forecast, by Application
8.4.6.5.4. Market size and forecast, by Design
8.4.6.5.5. Market size and forecast, by Age
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Product
8.4.6.6.3. Market size and forecast, by Application
8.4.6.6.4. Market size and forecast, by Design
8.4.6.6.5. Market size and forecast, by Age
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product
8.5.3. Market size and forecast, by Application
8.5.4. Market size and forecast, by Design
8.5.5. Market size and forecast, by Age
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Product
8.5.6.1.3. Market size and forecast, by Application
8.5.6.1.4. Market size and forecast, by Design
8.5.6.1.5. Market size and forecast, by Age
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Product
8.5.6.2.3. Market size and forecast, by Application
8.5.6.2.4. Market size and forecast, by Design
8.5.6.2.5. Market size and forecast, by Age
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Product
8.5.6.3.3. Market size and forecast, by Application
8.5.6.3.4. Market size and forecast, by Design
8.5.6.3.5. Market size and forecast, by Age
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Product
8.5.6.4.3. Market size and forecast, by Application
8.5.6.4.4. Market size and forecast, by Design
8.5.6.4.5. Market size and forecast, by Age
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2021
CHAPTER 10: COMPANY PROFILES
10.1. Evaheart, Inc.
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Key strategic moves and developments
10.2. Calon Cardio-Technology Ltd
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.3. Carmat SA
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Key strategic moves and developments
10.4. Fineheart
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Key strategic moves and developments
10.5. AdjuCor GmbH
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.6. Corewave SA
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Key strategic moves and developments
10.7. Bivacor Inc.
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Key strategic moves and developments
10.8. Windmill Cardiovascular Systems
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.9. NuPulseCV, Inc.
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.10. Abiomed, Inc.
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
10.10.7. Key strategic moves and developments
10.11. LivaNova PLC
10.11.1. Company overview
10.11.2. Key Executives
10.11.3. Company snapshot
10.11.4. Operating business segments
10.11.5. Product portfolio
10.11.6. Business performance
10.11.7. Key strategic moves and developments
10.12. Berlin Heart GmbH
10.12.1. Company overview
10.12.2. Key Executives
10.12.3. Company snapshot
10.12.4. Operating business segments
10.12.5. Product portfolio
10.12.6. Key strategic moves and developments
10.13. Jarvik Heart, Inc.
10.13.1. Company overview
10.13.2. Key Executives
10.13.3. Company snapshot
10.13.4. Operating business segments
10.13.5. Product portfolio
10.14. Abbott Laboratories
10.14.1. Company overview
10.14.2. Key Executives
10.14.3. Company snapshot
10.14.4. Operating business segments
10.14.5. Product portfolio
10.14.6. Business performance
10.14.7. Key strategic moves and developments
10.15. SynCardia Systems, LLC
10.15.1. Company overview
10.15.2. Key Executives
10.15.3. Company snapshot
10.15.4. Operating business segments
10.15.5. Product portfolio
10.15.6. Key strategic moves and developments
10.16. CH Biomedical, Inc.
10.16.1. Company overview
10.16.2. Key Executives
10.16.3. Company snapshot
10.16.4. Operating business segments
10.16.5. Product portfolio
10.16.6. Key strategic moves and developments
TABLE 01. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 02. VENTRICULAR ASSIST DEVICES MARKET FOR LEFT VENTRICULAR ASSIST DEVICES (LVADS), BY REGION, 2021-2031 ($MILLION)
TABLE 03. VENTRICULAR ASSIST DEVICES MARKET FOR RIGHT VENTRICULAR ASSIST DEVICES (RVADS), BY REGION, 2021-2031 ($MILLION)
TABLE 04. VENTRICULAR ASSIST DEVICES MARKET FOR BIVENTRICULAR ASSIST DEVICES (BIVADS), BY REGION, 2021-2031 ($MILLION)
TABLE 05. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 06. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT (BTT), BY REGION, 2021-2031 ($MILLION)
TABLE 07. VENTRICULAR ASSIST DEVICES MARKET FOR DESTINATION THERAPY, BY REGION, 2021-2031 ($MILLION)
TABLE 08. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-RECOVERY (BTR), BY REGION, 2021-2031 ($MILLION)
TABLE 09. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE TO CANDIDACY THERAPY, BY REGION, 2021-2031 ($MILLION)
TABLE 10. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 11. VENTRICULAR ASSIST DEVICES MARKET FOR TRANSCUTANEOUS VENTRICULAR ASSIST DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 12. VENTRICULAR ASSIST DEVICES MARKET FOR IMPLANTABLE VENTRICULAR ASSIST DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 13. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 14. VENTRICULAR ASSIST DEVICES MARKET FOR ADULTS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. VENTRICULAR ASSIST DEVICES MARKET FOR PEDIATRICS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 20. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 21. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 23. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 24. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 25. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 26. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 27. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 28. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 29. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 30. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 31. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 32. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 33. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 34. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 35. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 36. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 37. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 38. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 39. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 40. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 41. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 42. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 43. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 44. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 45. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 46. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 47. UK VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 48. UK VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 49. UK VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 50. UK VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 51. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 52. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 53. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 54. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 55. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 58. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 59. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 60. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 63. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 68. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 69. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 71. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 72. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 73. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 74. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 75. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 76. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 79. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 80. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 81. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 83. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 84. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 86. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 87. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 88. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 92. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 93. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 94. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 95. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 96. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 97. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 98. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 99. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 100. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 101. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 102. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 103. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 104. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 105. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 106. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 107. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 108. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 109. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 110. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 111. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 112. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 113. EVAHEART, INC.: KEY EXECUTIVES
TABLE 114. EVAHEART, INC.: COMPANY SNAPSHOT
TABLE 115. EVAHEART, INC.: PRODUCT SEGMENTS
TABLE 116. EVAHEART, INC.: PRODUCT PORTFOLIO
TABLE 117. EVAHEART, INC.: KEY STRATERGIES
TABLE 118. CALON CARDIO-TECHNOLOGY LTD: KEY EXECUTIVES
TABLE 119. CALON CARDIO-TECHNOLOGY LTD: COMPANY SNAPSHOT
TABLE 120. CALON CARDIO-TECHNOLOGY LTD: PRODUCT SEGMENTS
TABLE 121. CALON CARDIO-TECHNOLOGY LTD: PRODUCT PORTFOLIO
TABLE 122. CARMAT SA: KEY EXECUTIVES
TABLE 123. CARMAT SA: COMPANY SNAPSHOT
TABLE 124. CARMAT SA: PRODUCT SEGMENTS
TABLE 125. CARMAT SA: PRODUCT PORTFOLIO
TABLE 126. CARMAT SA: KEY STRATERGIES
TABLE 127. FINEHEART: KEY EXECUTIVES
TABLE 128. FINEHEART: COMPANY SNAPSHOT
TABLE 129. FINEHEART: PRODUCT SEGMENTS
TABLE 130. FINEHEART: PRODUCT PORTFOLIO
TABLE 131. FINEHEART: KEY STRATERGIES
TABLE 132. ADJUCOR GMBH: KEY EXECUTIVES
TABLE 133. ADJUCOR GMBH: COMPANY SNAPSHOT
TABLE 134. ADJUCOR GMBH: PRODUCT SEGMENTS
TABLE 135. ADJUCOR GMBH: PRODUCT PORTFOLIO
TABLE 136. COREWAVE SA: KEY EXECUTIVES
TABLE 137. COREWAVE SA: COMPANY SNAPSHOT
TABLE 138. COREWAVE SA: PRODUCT SEGMENTS
TABLE 139. COREWAVE SA: PRODUCT PORTFOLIO
TABLE 140. COREWAVE SA: KEY STRATERGIES
TABLE 141. BIVACOR INC.: KEY EXECUTIVES
TABLE 142. BIVACOR INC.: COMPANY SNAPSHOT
TABLE 143. BIVACOR INC.: PRODUCT SEGMENTS
TABLE 144. BIVACOR INC.: PRODUCT PORTFOLIO
TABLE 145. BIVACOR INC.: KEY STRATERGIES
TABLE 146. WINDMILL CARDIOVASCULAR SYSTEMS: KEY EXECUTIVES
TABLE 147. WINDMILL CARDIOVASCULAR SYSTEMS: COMPANY SNAPSHOT
TABLE 148. WINDMILL CARDIOVASCULAR SYSTEMS: PRODUCT SEGMENTS
TABLE 149. WINDMILL CARDIOVASCULAR SYSTEMS: PRODUCT PORTFOLIO
TABLE 150. NUPULSECV, INC.: KEY EXECUTIVES
TABLE 151. NUPULSECV, INC.: COMPANY SNAPSHOT
TABLE 152. NUPULSECV, INC.: PRODUCT SEGMENTS
TABLE 153. NUPULSECV, INC.: PRODUCT PORTFOLIO
TABLE 154. ABIOMED, INC.: KEY EXECUTIVES
TABLE 155. ABIOMED, INC.: COMPANY SNAPSHOT
TABLE 156. ABIOMED, INC.: PRODUCT SEGMENTS
TABLE 157. ABIOMED, INC.: PRODUCT PORTFOLIO
TABLE 158. ABIOMED, INC.: KEY STRATERGIES
TABLE 159. LIVANOVA PLC: KEY EXECUTIVES
TABLE 160. LIVANOVA PLC: COMPANY SNAPSHOT
TABLE 161. LIVANOVA PLC: PRODUCT SEGMENTS
TABLE 162. LIVANOVA PLC: PRODUCT PORTFOLIO
TABLE 163. LIVANOVA PLC: KEY STRATERGIES
TABLE 164. BERLIN HEART GMBH: KEY EXECUTIVES
TABLE 165. BERLIN HEART GMBH: COMPANY SNAPSHOT
TABLE 166. BERLIN HEART GMBH: PRODUCT SEGMENTS
TABLE 167. BERLIN HEART GMBH: PRODUCT PORTFOLIO
TABLE 168. BERLIN HEART GMBH: KEY STRATERGIES
TABLE 169. JARVIK HEART, INC.: KEY EXECUTIVES
TABLE 170. JARVIK HEART, INC.: COMPANY SNAPSHOT
TABLE 171. JARVIK HEART, INC.: PRODUCT SEGMENTS
TABLE 172. JARVIK HEART, INC.: PRODUCT PORTFOLIO
TABLE 173. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 174. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 175. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 176. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 177. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 178. SYNCARDIA SYSTEMS, LLC: KEY EXECUTIVES
TABLE 179. SYNCARDIA SYSTEMS, LLC: COMPANY SNAPSHOT
TABLE 180. SYNCARDIA SYSTEMS, LLC: PRODUCT SEGMENTS
TABLE 181. SYNCARDIA SYSTEMS, LLC: PRODUCT PORTFOLIO
TABLE 182. SYNCARDIA SYSTEMS, LLC: KEY STRATERGIES
TABLE 183. CH BIOMEDICAL, INC.: KEY EXECUTIVES
TABLE 184. CH BIOMEDICAL, INC.: COMPANY SNAPSHOT
TABLE 185. CH BIOMEDICAL, INC.: PRODUCT SEGMENTS
TABLE 186. CH BIOMEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 187. CH BIOMEDICAL, INC.: KEY STRATERGIES
